Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12559906 | 0.90 | FAAH (0.41) | HCAR2ALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL24609944 | 0.90 | PTGS2 (0.50) | HCAR2ALDH1A1MAPTLPAR1FFAR1 | |
| SCHEMBL3883004 | 0.85 | HCAR2 (0.56) | HCAR2ALDH1A1KDM4EMAPTTSHR | |
| SCHEMBL11461421 | 0.85 | HCAR2 (0.56) | HCAR2ALDH1A1KDM4EMAPTTSHR | |
| SCHEMBL24609951 | 0.84 | GPR139 (0.46) | HCAR2ALDH1A1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL22699890 | 0.83 | ALDH1A1 (0.44) | HCAR2ALDH1A1KDM4EMAPTFFAR1 | |
| SCHEMBL9231000 | 0.83 | HCAR2 (0.54) | HCAR2ALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL27774184 | 0.83 | HCAR2 (0.54) | HCAR2ALDH1A1KDM4EMAPTTSHR | |
| SCHEMBL27701745 | 0.83 | HCAR2 (0.54) | HCAR2ALDH1A1KDM4EMAPTTSHR | |
| SCHEMBL538486 | 0.83 | HCAR2 (0.54) | HCAR2ALDH1A1LMNAKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773215-B | Oil field oily sewage oil removing agent and preparation method and application thereof | 山东科兴化工有限责任公司 | 2022-09-02 | — | — | CN | claimed |
| CN-114773215-A | Oil field oily sewage oil removing agent and preparation method and application thereof | 山东科兴化工有限责任公司 | 2022-07-22 | — | — | CN | claimed |
| EP-2319825-A1 | ENZYMATIC SYNTHESIS OF ENANTIOMERICALLY ENRICHED DERIVATIVES OF CIS- AND TRANS-CYCLOPENTANE-1,2-DIAMINES | EntreChem, S.L. (ES) | 2011-05-11 | — | — | EP | claimed |
| US-12493241-B2 | Photoacid generators, photoresist compositions, and pattern formation methods | DUPONT ELECTRONIC MAT INTERNATIONAL LLC (US) | 2025-12-09 | — | — | US | disclosed |
| US-20250116927-A1 | PHOTOACID GENERATORS, PHOTORESIST COMPOSITIONS, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2025-04-10 | — | — | US | disclosed |
| US-12140866-B2 | Photoacid generators, photoresist compositions, and pattern formation methods | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2024-11-12 | — | — | US | disclosed |
| CN-116284530-B | Preparation method and application of butyl rubber | 山东京博中聚新材料有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-116284530-A | Preparation method and application of butyl rubber | 山东京博中聚新材料有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-114773215-B | Oil field oily sewage oil removing agent and preparation method and application thereof | 山东科兴化工有限责任公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-114773215-A | Oil field oily sewage oil removing agent and preparation method and application thereof | 山东科兴化工有限责任公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20220214614-A1 | PHOTOACID GENERATORS, PHOTORESIST COMPOSITIONS, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-07-07 | — | — | US | disclosed |
| US-20220214614-A1 | PHOTOACID GENERATORS, PHOTORESIST COMPOSITIONS, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-07-07 | — | — | US | disclosed |
| CN-114690553-A | Photoacid generator, photoresist composition, and pattern forming method | 罗门哈斯电子材料有限责任公司 | 2022-07-01 | — | — | CN | disclosed |
| EP-2319825-A1 | ENZYMATIC SYNTHESIS OF ENANTIOMERICALLY ENRICHED DERIVATIVES OF CIS- AND TRANS-CYCLOPENTANE-1,2-DIAMINES | EntreChem, S.L. (ES) | 2011-05-11 | — | — | EP | disclosed |
| EP-0752465-A1 | Betaine esters for delivery of alcohols | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-08 | — | — | EP | disclosed |
| WO-1996038528-A1 | BETAINE ESTERS FOR DELIVERY OF ALCOHOLS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12493241-B2 | Photoacid generators, photoresist compositions, and pattern formation methods | ARF1, ARL1, GNA11 | HCAR2 1526/4885ALDH1A1 312/4885LMNA 3392/4885 |
| US-12140866-B2 | Photoacid generators, photoresist compositions, and pattern formation methods | ARF1, ARL1, GNA11 | HCAR2 1526/4885ALDH1A1 312/4885LMNA 3392/4885 |
| US-20250116927-A1 | PHOTOACID GENERATORS, PHOTORESIST COMPOSITIONS, AND PATTERN FORMATION METHODS | ARF1, ARL1, GNA11 | HCAR2 1526/4885ALDH1A1 312/4885LMNA 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.